Sodium Tetradecyl Sulfate Injection Recalled for Lack of Sterility Assurance
Olympia Pharmacy is recalling 588 vials of Sodium Tetradecyl Sulfate 5% injection nationwide due to inability to assure product sterility. The multi-dose vials carry a potential contamination risk for patients.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable medication. Sterility assurance failure in injectable drugs represents a risk-of-harm product scenario per the severity rubric, placing it in the High category.
Plain-English summary
Olympia Compounding Pharmacy is recalling 588 vials of Sodium Tetradecyl Sulfate 5% MDV (multi-dose vial) injection due to lack of assurance of sterility. The affected product is NDC 73198-0102-05, Lot L24306, with a Breakdown Date of June 6, 2022.
The product was distributed nationwide throughout the United States, Puerto Rico, and the U.S. Virgin Islands. Sodium Tetradecyl Sulfate is a prescription medication used for injection; inability to assure sterility in injectable medications presents a potential contamination risk.
Patients currently using this product should consult their healthcare provider immediately. Healthcare providers and patients should not use vials from the identified lot number and should contact Olympia Pharmacy or their healthcare provider for replacement medication or further guidance.
The recalled product
- Product
- Sodium Tetradecyl Sulfate 5% MDV Injection, Multi-Dose 5 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0102-05
- Manufacturer
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Category
- Drug
- Hazard
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: L24306 BUD: 6/6/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27